Tuesday, May 16, 2017 5:03:30 PM
EDIT...when I saw Chardan Capital Markets price target of $65 I thought these guys need to explain why $65 on an $18-20 stock...$25-30 would seem more acceptable...
I'm sure there's some pump and dumpers talking up this "potential"...just listen to signals at signals until news confirms the hype this is not for the faint of heart...swing trades is all I want for now...
Is Editas Facing a New Reality in CRISPR Land?
Editas Medicine Inc. (EDIT) is one of the biotech and biohealth players that sits on the cusp of new technology and developments for the next major growth phase in health care: CRISPR. Big opportunities in emerging health care companies often come with very bumpy rides. There is also the risk, of course, that there are no assurances that the potential promise and upside will come true in the future. Editas shares were lower after its earnings report, but the main culprit is a delay to the company's Leber congenital amaurosis (LCA) treatment. This is a rare, degenerative disease in the retina that causes blindness in children.
%B which is "PRICE" and the Grail averages say weak =hints down...
Stochastics is saying weak...the Stochastic Oscillator is a momentum indicator that shows the location of the close relative to the high-low range over a set number of periods. According to an interview with Lane, the Stochastic Oscillator “doesn't follow price, it doesn't follow volume or anything like that. It follows the speed or the momentum of price. As a rule, the momentum changes direction before price.” As such, bullish and bearish divergences in the Stochastic Oscillator can be used to foreshadow reversals. This was the first, and most important, signal that Lane identified. Lane also used this oscillator to identify bull and bear set-ups to anticipate a future reversal. Because the Stochastic Oscillator is range bound, is also useful for identifying overbought and oversold levels.
I'm sure there's some pump and dumpers talking up this "potential"...just listen to signals at signals until news confirms the hype this is not for the faint of heart...swing trades is all I want for now...
Is Editas Facing a New Reality in CRISPR Land?
Editas Medicine Inc. (EDIT) is one of the biotech and biohealth players that sits on the cusp of new technology and developments for the next major growth phase in health care: CRISPR. Big opportunities in emerging health care companies often come with very bumpy rides. There is also the risk, of course, that there are no assurances that the potential promise and upside will come true in the future. Editas shares were lower after its earnings report, but the main culprit is a delay to the company's Leber congenital amaurosis (LCA) treatment. This is a rare, degenerative disease in the retina that causes blindness in children.
%B which is "PRICE" and the Grail averages say weak =hints down...
Stochastics is saying weak...the Stochastic Oscillator is a momentum indicator that shows the location of the close relative to the high-low range over a set number of periods. According to an interview with Lane, the Stochastic Oscillator “doesn't follow price, it doesn't follow volume or anything like that. It follows the speed or the momentum of price. As a rule, the momentum changes direction before price.” As such, bullish and bearish divergences in the Stochastic Oscillator can be used to foreshadow reversals. This was the first, and most important, signal that Lane identified. Lane also used this oscillator to identify bull and bear set-ups to anticipate a future reversal. Because the Stochastic Oscillator is range bound, is also useful for identifying overbought and oversold levels.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
